305 related articles for article (PubMed ID: 18089792)
1. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY
Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of deguelin-induced apoptosis in transformed human bronchial epithelial cells.
Lee HY
Biochem Pharmacol; 2004 Sep; 68(6):1119-24. PubMed ID: 15313408
[TBL] [Abstract][Full Text] [Related]
3. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells.
Chun KH; Kosmeder JW; Sun S; Pezzuto JM; Lotan R; Hong WK; Lee HY
J Natl Cancer Inst; 2003 Feb; 95(4):291-302. PubMed ID: 12591985
[TBL] [Abstract][Full Text] [Related]
4. Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR.
Cai Y; Wang Q; Ling Z; Pipeleers D; McDermott P; Pende M; Heimberg H; Van de Casteele M
Biochem Pharmacol; 2008 May; 75(10):1981-93. PubMed ID: 18377870
[TBL] [Abstract][Full Text] [Related]
5. Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells.
Chen W; Wang X; Zhuang J; Zhang L; Lin Y
Carcinogenesis; 2007 Oct; 28(10):2114-21. PubMed ID: 17548900
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the activities of AMP-activated protein kinase, protein kinase B, and mammalian target of rapamycin by limiting energy availability with 2-deoxyglucose.
Jiang W; Zhu Z; Thompson HJ
Mol Carcinog; 2008 Aug; 47(8):616-28. PubMed ID: 18247380
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer.
Krysan K; Dalwadi H; Sharma S; Põld M; Dubinett S
Cancer Res; 2004 Sep; 64(18):6359-62. PubMed ID: 15374938
[TBL] [Abstract][Full Text] [Related]
8. Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer.
Carretero J; Medina PP; Blanco R; Smit L; Tang M; Roncador G; Maestre L; Conde E; Lopez-Rios F; Clevers HC; Sanchez-Cespedes M
Oncogene; 2007 Mar; 26(11):1616-25. PubMed ID: 16953221
[TBL] [Abstract][Full Text] [Related]
9. Deguelin-induced inhibition of cyclooxygenase-2 expression in human bronchial epithelial cells.
Lee HY; Suh YA; Kosmeder JW; Pezzuto JM; Hong WK; Kurie JM
Clin Cancer Res; 2004 Feb; 10(3):1074-9. PubMed ID: 14871987
[TBL] [Abstract][Full Text] [Related]
10. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
Xu Y; Chen SY; Ross KN; Balk SP
Cancer Res; 2006 Aug; 66(15):7783-92. PubMed ID: 16885382
[TBL] [Abstract][Full Text] [Related]
11. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
Han S; Khuri FR; Roman J
Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
[TBL] [Abstract][Full Text] [Related]
12. Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions.
Balsara BR; Pei J; Mitsuuchi Y; Page R; Klein-Szanto A; Wang H; Unger M; Testa JR
Carcinogenesis; 2004 Nov; 25(11):2053-9. PubMed ID: 15240509
[TBL] [Abstract][Full Text] [Related]
13. Regulation of endothelial cell cycle by laminar versus oscillatory flow: distinct modes of interactions of AMP-activated protein kinase and Akt pathways.
Guo D; Chien S; Shyy JY
Circ Res; 2007 Mar; 100(4):564-71. PubMed ID: 17272808
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
[TBL] [Abstract][Full Text] [Related]
15. The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF-kappaB pathway.
Dell'Eva R; Ambrosini C; Minghelli S; Noonan DM; Albini A; Ferrari N
Carcinogenesis; 2007 Feb; 28(2):404-13. PubMed ID: 16952909
[TBL] [Abstract][Full Text] [Related]
16. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
[TBL] [Abstract][Full Text] [Related]
17. Survivin gene expression in early-stage non-small cell lung cancer.
Falleni M; Pellegrini C; Marchetti A; Oprandi B; Buttitta F; Barassi F; Santambrogio L; Coggi G; Bosari S
J Pathol; 2003 Aug; 200(5):620-6. PubMed ID: 12898598
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1.
Zheng Y; Ritzenthaler JD; Sun X; Roman J; Han S
Cancer Res; 2009 Feb; 69(3):896-904. PubMed ID: 19176380
[TBL] [Abstract][Full Text] [Related]
19. Suppression of mTOR via Akt-dependent and -independent mechanisms in selenium-treated colon cancer cells: involvement of AMPKalpha1.
Lee YK; Park SY; Kim YM; Kim DC; Lee WS; Surh YJ; Park OJ
Carcinogenesis; 2010 Jun; 31(6):1092-9. PubMed ID: 20164123
[TBL] [Abstract][Full Text] [Related]
20. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.
Tanabe H; Yagihashi A; Tsuji N; Shijubo Y; Abe S; Watanabe N
Lung Cancer; 2004 Dec; 46(3):299-304. PubMed ID: 15541814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
